GIP
GIP is a pharmaceutical drug with 13 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
9 of 9 finished
0.0%
0 ended early
3
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals
Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury
Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19
Clinical Trials (13)
Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 Infusion
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals
Gut Peptides and Bone Remodeling in Individuals With Spinal Cord Injury
Effects of Gut Peptides on Bone Remodeling. KS-4-Diabetes-19
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
Gut Hormones and Bone Remodeling in Humans (KS-2)
Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.
Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle
Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes
GIP and GLP-1 in Type 1 Diabetes
Hyperglycemia and the Extra-pancreatic Effect of Incretins
GIP: Glucose-dependent Insulinotropic Peptide
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13